jmkx003002
Small moleculeexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 9, 2023 (NCT05907382)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06800651 | Phase 2 | Mar 13, 2025 | Jemincare, Peking University |
| NCT06664125 | Phase 2 | Dec 30, 2024 | Jemincare |
| NCT06079541 | Phase 1 | Jul 6, 2023 | Fudan University, Government of China, Jemincare |
| NCT05907382 | Phase 1 | May 9, 2023 | Fudan University, Jemincare |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jemincare | For profit | 4 | 4 | 2 | 2023 |
| Fudan University | Academic/Hospital | 2 | 0 | 1 | 2023 |
| Government of China | Government | 1 | 0 | 1 | 2023 |
| Peking University | Academic/Hospital | 1 | 0 | 1 | 2025 |
4 organizations
Page 1 / 1